Biotech company 23andMe was once hailed as one of the most successful businesses selling DNA analysis services to anybody who could afford one of its saliva test kits. But 18 years after it was ...
DNA-testing company 23andMe said late Wednesday that it was considering splitting itself in two, one possible effort to resurrect its sub-$1 share price. Investors seemed unmoved, with 23and Me stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback